Volatile anesthetics in ischemic liver injury: Enemy or friend?

Hepatitis Monthly

Volumn 14, Issue 6, 2014, Pages

  Mohseni, Masood ^a   Safari, Saeid ^a,b   Alavian, Seyed Moayed ^b,c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Middle East Liver Diseases Center   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anesthesiology; Anesthetics; Inhalation; Intraoperative care; Liver diseases; Perioperative care

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; ANTIOXIDANT; DESFLURANE; ENFLURANE; HALOTHANE; HEME OXYGENASE 1; INHALATION ANESTHETIC AGENT; ISOFLURANE; MATRIX METALLOPROTEINASE INHIBITOR; NITRIC OXIDE; OPIATE; PENTOXIFYLLINE; PROSTAGLANDIN; PROTEINASE INHIBITOR; SEVOFLURANE;

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG TRANSFORMATION; FATTY LIVER; HUMAN; LIVER BLOOD FLOW; LIVER DYSFUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; REPERFUSION INJURY; SURGICAL MORTALITY;

EID: 84903384757     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.19880     Document Type: Article

References (41)

1. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg. 2010;97(10):1461-1475.
2. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis -epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5-6):129-139.
3. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-re-perfusion injury. Am J Surg. 2001;181(2):160-166.
4. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238(6):843-850.
5. Heidenberg WJ, Torio IS, Cebula J. Halothane hepatitis. An American disease? Lancet. 1963;1(7292):85-86.
6. Lehmann K, Clavien PA. History of hepatic surgery. Surg Clin North Am. 2010;90(4):655-64.
7. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356(15):1545-1559.
8. Khajavi M, Emami A, Etezadi F, Safari S, Sharif A, Shariat Moharari R. Conscious Sedation and Analgesia in Colonoscopy: Ketamine/ Propofol Combination has Superior Patient Satisfaction Versus Fentanyl/Propofol. Anesth Pain Med. 2013;3(1):208-213.
9. Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, et al. Remifentanil preconditioning reduces hepatic ischemia-reper-fusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology. 2011;114(5):1036-1047.
10. Azmude A, Agha'amou S, Yousefshahi F, Berjis K, Mirmohammad'khani M, Sadaat'ahmadi F, et al. Pregnancy outcome using general anesthesia versus spinal anesthesia for in vitro fertilization. Anesth Pain Med. 2013;3(2):239-242.
11. Khan ZH. Pain management in intensive care unit patients: the role of ultra-short acting opioid: remifentanil. Anesth Pain Med. 2013;3(1):188-190.
12. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248(6):909-918.
13. Selzner N, Boehnert M, Selzner M. Preconditioning, postcondi-tioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications. Transplant Rev (Orlando). 2012;26(2):115-124.
14. Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev. 2009;(1):CD007629.
15. Theodoraki K, Tympa A, Karmaniolou I, Tsaroucha A, Arkadopoulos N, Smyrniotis V. Ischemia/reperfusion injury in liver resection: a review of preconditioning methods. Surg Today. 2011;41(5):620-629.
16. Beck-Schimmer B, Breitenstein S, Bonvini JM, Lesurtel M, Ganter M, Weber A, et al. Protection of pharmacological postcondition-ing in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012;256(5):837-844.
17. Maines MD. The heme oxygenase system: update 2005. Antioxid Redox Signal. 2005;7(11-12):1761-1766.
18. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86(2):583-650.
19. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19(12):1617-1626.
20. Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Ala-vian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon. 2011;11(1):3-6.
21. Dabbagh A, Rajaei S. The Role of Anesthetic Drugs in Liver Apop-tosis. Hepat Mon. 2013;13(8):e13162
22. Mahboobi N, Esmaili S, Safari S, Habibollahi P, Dabbagh A, Ala-vian SM. Halothane: How should it be treated in a developing country? EMHJ. 2011.
23. Gut J. Molecular basis of halothane hepatitis. Arch Toxicol Suppl. 1998;20:3-17.
24. Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Ala-vian SM. Halothane-induced hepatitis: A forgotten issue in developing countries. Hepat Mon. 2011;11(1):3.
25. Eger EI, 2nd, Smuckler EA, Ferrell LD, Goldsmith CH, Johnson BH. Is enfurane hepatotoxic? Anesth Analg. 1986;65(1):21-30.
26. Elliott RH, Strunin L. Hepatotoxicity of volatile anaesthetics. Br J Anaesth. 1993;70(3):339-348.
27. Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol. 1987;65(8):1762-1779.
28. Holaday DA, Fiserova-Bergerova V, Latto IP, Zumbiel MA. Resistance of isofurane to biotransformation in man. Anesthesiology. 1975;43(3):325-332.
29. Gunza JT, Pashayan AG. Postoperative elevation of serum transaminases following isofurane anesthesia. J Clin Anesth. 1992;4(4):336-341.
30. Brunt EM, White H, Marsh JW, Holtmann B, Peters MG. Fulminant hepatic failure after repeated exposure to isofurane anesthesia: a case report. Hepatology. 1991;13(6):1017-1021.
31. Turner GB, O'Rourke D, Scott GO, Beringer TR. Fatal hepatotoxic-ity after re-exposure to isofurane: a case report and review of the literature. Eur J Gastroenterol Hepatol. 2000;12(8):955-959.
32. Hoetzel A, Leitz D, Schmidt R, Tritschler E, Bauer I, Loop T, et al. Mechanism of hepatic heme oxygenase-1 induction by isofu-rane. Anesthesiology. 2006;104(1):101-109.
33. Gatecel C, Losser MR, Payen D. The postoperative effects of halo-thane versus isofurane on hepatic artery and portal vein blood flow in humans. Anesth Analg. 2003;96(3):740-745.
34. Kanaya N, Nakayama M, Fujita S, Namiki A. Comparison of the effects of sevofurane, isofurane and halothane on indocyanine green clearance. Br J Anaesth. 1995;74(2):164-167.
35. Bedirli N, Ofuoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, et al. Hepatic energy metabolism and the differential protective efects of sevofurane and isofurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 2008;106(3):830-837.
36. Sutton TS, Koblin DD, Gruenke LD, Weiskopf RB, Rampil IJ, Waskell L, et al. Fluoride metabolites after prolonged exposure of volunteers and patients to desfurane. Anesth Analg. 1991;73(2):180-185.
37. Malhotra P, Mychaskiw G, Rai A. Desfurane versus opioid anesthesia for cardiac shunt procedures in infants with cyantoic con-gential heart disease. Anesth Pain Med. 2013;3(1):191-197.
38. Hartman JC, Pagel PS, Proctor LT, Kampine JP, Schmeling WT, Warl-tier DC. Influence of desfurane, isofurane and halothane on regional tissue perfusion in dogs. Can J Anaesth. 1992;39(8):877-887.
39. Weiskopf RB, Eger EI, 2nd, Ionescu P, Yasuda N, Cahalan MK, Freire B, et al. Desfurane does not produce hepatic or renal injury in human volunteers. Anesth Analg. 1992;74(4):570-574.
40. Ko JS, Gwak MS, Choi SJ, Kim GS, Kim JA, Yang M, et al. The efects of desfurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl. 2008;14(8):1150-1158.
41. Kotake Y. Anesthetic protection against hepatic injury. Masui. 2006;55(5):570-578.